Long-term, low-dose aspirin did not affect risk of dementia in adults with type 2 diabetes American Heart Association Scientific Sessions 2021, LBS.07
Research Highlights:
- Daily low-dose aspirin taken for an average of seven years did not affect the risk of dementia in adults with type 2 diabetes.
- The aspirin regimen was neither protective nor harmful regarding dementia risk.
- A heart attack or stroke was associated with at […]
Monitoring for individual triggers may reduce episodes of atrial fibrillation – American Heart Association Scientific Sessions 2021, LBS.04
Research Highlights:
- Personalized testing may help identify triggers for irregular heart rhythms and reduce their frequency in people with atrial fibrillation.
- Alcohol consumption was linked to having an atrial fibrillation episode.
- Caffeine did not appear to increase the risk for an episode of atrial fibrillation.
Embargoed […]
-
Heart failure symptoms improved with a type 2 diabetes medicine in fully remote trial – American Heart Association Scientific Sessions 2021, LBS.05 GalleryHeart failure symptoms improved with a type 2 diabetes medicine in fully remote trial – American Heart Association Scientific Sessions 2021, LBS.05
Heart failure symptoms improved with a type 2 diabetes medicine in fully remote trial – American Heart Association Scientific Sessions 2021, LBS.05
Research Highlights:
- Adults with heart failure who took canagliflozin, a medication originally developed to treat type 2 diabetes, reported improvements in their heart failure symptoms whether or not they also had type 2 diabetes.
- Symptom and quality of life benefits were evident as early […]
-
Adults with acute heart failure benefit when treated with a type 2 diabetes medication – American Heart Association Scientific Sessions 2021, LBS.05 GalleryAdults with acute heart failure benefit when treated with a type 2 diabetes medication – American Heart Association Scientific Sessions 2021, LBS.05
Adults with acute heart failure benefit when treated with a type 2 diabetes medication – American Heart Association Scientific Sessions 2021, LBS.05
Research Highlights:
- When treated with empagliflozin, adults hospitalized for acute heart failure were 36% more likely to have a clinical benefit, such as a reduction in all-cause mortality, reduction in heart failure events, or an improvement in heart failure symptoms.
- Empagliflozin was originally primarily […]
-
Stem cell therapy for heart failure reduced major CV events and death, not hospitalization – American Heart Association Scientific Sessions 2021, LBS.05 GalleryStem cell therapy for heart failure reduced major CV events and death, not hospitalization – American Heart Association Scientific Sessions 2021, LBS.05
Stem cell therapy for heart failure reduced major CV events and death, not hospitalization – American Heart Association Scientific Sessions 2021, LBS.05
Research Highlights:
- Adults with chronic, class II or III heart failure with reduced ejection fraction (HFrEF), as defined by the New York Heart Association criteria, who were treated with stem cells experienced a 65% reduction in non-fatal heart attack or stroke events.
- In NYHA […]
50 Years On, Real Progress in War Against Cancer
[…]
-
Blood thinners may prevent cognitive decline in older patients with atrial fibrillation – American Heart Association Scientific Sessions 2021, LBS.03 GalleryBlood thinners may prevent cognitive decline in older patients with atrial fibrillation – American Heart Association Scientific Sessions 2021, LBS.03
Blood thinners may prevent cognitive decline in older patients with atrial fibrillation – American Heart Association Scientific Sessions 2021, LBS.03
Research Highlights:
- A randomized, multi-center, international trial found that when adequately used, prescribed at the correct dosage and taken appropriately by patients for two years, there was no difference between the anticoagulant medications dabigatran and warfarin in preventing cognitive decline.
- Oral anticoagulants – medications […]
Exercise Helps Ease Arm, Shoulder Pain After Breast Cancer Surgery
[…]
-
Village doctor-led intervention effective in BP control, adds health care access options American Heart Association Scientific Sessions 2021, Presentation LBS.02 GalleryVillage doctor-led intervention effective in BP control, adds health care access options American Heart Association Scientific Sessions 2021, Presentation LBS.02
Village doctor-led intervention effective in BP control, adds health care access options American Heart Association Scientific Sessions 2021, Presentation LBS.02
Research Highlights:
- High blood pressure is a leading, preventable risk factor for cardiovascular disease and death from all causes, yet many people in low- and middle-income countries do not have their blood pressure controlled to optimal levels, often because they don’t have access […]
